Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study
about
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reportsRole of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug usersPooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillanceReduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.Accounting for the increase in NSAID expenditure: substitution or leakage?Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trialNon-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials.Endoscopic ulcers as a surrogate marker of NSAID-induced mucosal damage.Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses.Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts.New dogmas or old?Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy VolunteersGastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?Utilisation of non-steroidal anti-inflammatory drugs (NSAIDs) through community pharmacies in Malaysia.Use of a cyclo-oxygenase 2 inhibitor for prophylaxis of cystoid macular oedema following cataract surgery: a randomized placebo-controlled trial.Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity
P2860
Q24816687-1D41540B-4951-4705-9D5A-61034617D62EQ28182449-DE26597B-90E6-434C-A2E0-7D6B9ED5038FQ33516504-D3FF3C5C-45E3-4CAF-80A5-32492C8AB3BAQ34548071-501BDDED-2AD4-48EA-AA15-391D61DE8BE2Q34768089-6EBB5E21-6A02-4D49-87CA-7C2C24573B98Q35520722-1FDC095F-8E9B-49B4-8E19-FBBE0634AAB3Q37257464-69B8A1A1-343D-496D-8724-0D1763BFEC7DQ37476761-F1B6540B-5A91-47DD-906C-89795398A05EQ37893966-C86D2890-C6C9-48F6-BE68-E11DC106076CQ38993297-994853F6-DAF2-4FAA-99BE-9D40A8D905DFQ40537203-63E331F4-8C35-4CDB-B111-EA1BA18F20D6Q41903025-AC258CD3-B350-4499-B04C-493DC6864F98Q42359900-FF7B6B01-DE02-4509-A7F3-D81A524B7E34Q43266149-6F071037-D8EC-40A5-820D-4E598D154CC6Q44808671-56B471F4-4B93-4DB6-B415-E003F06C9A33Q46903259-93873178-BDB4-4A78-B79B-583006C5AA71Q48691658-560DBC88-80EF-4C2C-A48F-5DDE9441B462Q57169425-F0473E50-527C-4AAE-9EA4-E41E303FB9CF
P2860
Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Incidence of gastroduodenal ul ...... randomised, double blind study
@ast
Incidence of gastroduodenal ul ...... randomised, double blind study
@en
type
label
Incidence of gastroduodenal ul ...... randomised, double blind study
@ast
Incidence of gastroduodenal ul ...... randomised, double blind study
@en
prefLabel
Incidence of gastroduodenal ul ...... randomised, double blind study
@ast
Incidence of gastroduodenal ul ...... randomised, double blind study
@en
P2093
P2860
P356
P1433
P1476
Incidence of gastroduodenal ul ...... randomised, double blind study
@en
P2093
C J Hawkey
Rofecoxib Rheumatoid Arthritis Endoscopy Study Group
P2860
P304
P356
10.1136/GUT.52.6.820
P407
P577
2003-06-01T00:00:00Z